Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
Clinical trial NCT06422533 · UNKNOWN
Trial details
- NCT number
- NCT06422533
- Sponsor
- Instituto Nacional de Cancerologia de Mexico
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2025-07-31
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.